- ►diabetesjournals.org AA Eid, Y Gorin, BM Fagg, R Maalouf, JL … - Diabetes, 2009 - Am Diabetes Assoc OBJECTIVE We investigated the role of cytochrome P450 of the 4A family (CYP4A),
its metabolites, and NADPH oxidases both in reactive oxygen species (ROS)
production and apoptosis of podocytes exposed to high glucose and in OVE26 ... Cited by 2 - Related articles - All 3 versions
FN Ziyadeh - Diabetes research and clinical practice, 2008 - Elsevier Hemodynamic stress in concert with metabolic pathways that are activated by
hyperglycemia, glycated proteins, and oxidative stress induce a host of growth
factors in the kidney. The fibrogenic cytokine transforming growth ... Cited by 6 - Related articles - All 11 versions
SH Han, S Yang, DS Jung, JJ Li, JJ Kim, SJ … - Biochemical and biophysical research communications, 2008 - Elsevier To explore the mechanisms of podocyte injury under diabetic conditions, we
performed an expression profile in glucose-stimulated podocytes. Differential
gene expression profiles between conditionally immortalized mouse podocytes ... Cited by 3 - Related articles - All 4 versions
L Barisoni, HW Schnaper, JB Kopp - Archives of pathology & laboratory medicine, 2009 - ncbi.nlm.nih.gov CONTEXT: Etiologic factors and pathways leading to altered podocyte phenotype
are clearly numerous and involve the activity of different cellular function.
OBJECTIVE: To focus on recent discoveries in podocyte biology and genetics ... Cited by 3 - Related articles
KH Jeong, TW Lee, CG Ihm, SH Lee, JY Moon … - American Journal of Nephrology, 2008 - content.karger.com Background: Oxidative stress and inflammation are implicated in the pathogenesis
of diabetic nephropathy. Because sildenafil citrate (Viagra®) has variable
cardiovascular benefits, including antioxidative and immunomodulating ... Cited by 3 - Related articles - All 4 versions
KV Lemley - Pediatric Nephrology, 2008 - Springer Abstract Although diabetic nephropathy is a very rare cause of kidney failure
during childhood, the underlying events leading to progressive kidney injury
begin during childhood in many patients with type 1 diabetes mellitus ... Cited by 4 - Related articles - All 2 versions
- ►uhp-nancy.fr [PDF] M Portero-Otín, R Pamplona, J Boada, M Jové, … - Biochemical and Biophysical Research …, 2008 - Elsevier Renin angiotensin system (RAS) worsens diabetic nephropathy (DN) by increasing
oxidative stress. We compared the effect of three different RAS inhibitors: the
angiotensin converting enzyme inhibitor Ramipril, the vasopeptidase ... Cited by 4 - Related articles - All 4 versions
C Rüster, T Bondeva, S Franke, N Tanaka, H … - American Journal of Nephrology, 2009 - content.karger.com Background: Advanced glycation end products (AGEs) play an important role in
diabetic nephropathy. The receptor for AGEs, called RAGE, is present on
podocytes. We investigated whether angiotensin II (ANG II) modulates RAGE ... Cited by 4 - Related articles - All 4 versions
M Iglarz, C Binkert, K Morrison, W Fischli, J … - Journal of Pharmacology and Experimental …, 2008 - ASPET Macitentan, also called Actelion-1 or ACT-064992 [N-[5-(4-bromophenyl)-6-(2-(5-
bromopyrimidin-2-yloxy)ethoxy)-pyrimidin-4-yl]-N'-propylaminosulfonamide], is a
new dual ET A /ET B endothelin (ET) receptor antagonist designed for tissue ... Cited by 4 - Related articles - All 4 versions
